$4.57
+0.13 (+2.93%)
Open$4.55
Previous Close$4.44
Day High$4.62
Day Low$4.51
52W High$23.20
52W Low$3.67
Volume—
Avg Volume6.31M
Market Cap623.81M
P/E Ratio—
EPS$-1.06
SectorPharmaceuticals
Analyst Ratings
Hold
17 analysts
Price Target
+826.0% upside
Current
$4.57
$4.57
Target
$42.32
$42.32
$27.22
$42.32 avg
$56.32
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.12B | 985.00M | 180.40M |
| Net Income | -148,172,517 | -117,555,769 | 49.45M |
| Profit Margin | -13.3% | -12.6% | 27.4% |
| EBITDA | -53,030,882 | -44,410,558 | 94.91M |
| Free Cash Flow | — | — | 60.57M |
| Rev Growth | +13.4% | +13.4% | -1.4% |
| Debt/Equity | 0.22 | 0.22 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |